Zevra Therapeutics Inc. (ZVRA)
Zevra Therapeutics Max Pain By Strike
ZVRA trades at $9.48, 5.3% above the near-term max pain of $9 expiring Sep 19, 2025 (29 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$11), reflecting growing call interest at higher strikes. Key magnetic zone at 7 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Zevra Therapeutics Max Pain By Expiry
Max pain for ZVRA shows an upward trend from 1 to 11, suggesting bullish positioning in longer-dated options. The 140% spread signals divergent expectations across timeframes. Most levels below 9.48 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 9 | -0.48 (-5.06%) |
| Oct 17, 2025 | 11 | 1.52 (16.03%) |
| Nov 21, 2025 | 10 | 0.52 (5.49%) |
| Jan 16, 2026 | 7 | -2.48 (-26.16%) |
| Feb 20, 2026 | 5 | -4.48 (-47.26%) |
| Dec 18, 2026 | 1 | -8.48 (-89.45%) |
| Jan 15, 2027 | 7 | -2.48 (-26.16%) |